Literature DB >> 23482670

Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.

Miaoxia He1, Changjing Zuo, Jianjun Wang, Jianmin Liu, Binghua Jiao, Jianmin Zheng, Zailong Cai.   

Abstract

BACKGROUND: Primary central nervous system lymphomas, predominantly diffuse large B-cell lymphomas (PCNS-DLBCL), are aggressive malignancies, and no histopathological variables with independent prognostic value are currently available. The aim of this study is to determine the prognostic value of histopathological variables of PCNS-DLBCL.
METHODS: Aggregative perivascular tumor cells (APVTs) and reactive perivascular T cell infiltrates (RPVIs) in tumor samples from 62 immunocompetent patients with PCNS-DLBCL were histopathologically and immunohistochemically studied. A mouse brain DLBCL model was established to confirm the special morphological features of PCNS-DLBCL. The therapy, overall response rate (ORR), and overall survival (OS) among patients were followed up.
RESULTS: APVT was present in 54 (87%) of the 62 cases, whereas RPVI was present in 20 (32%). Patients with APVT-positive lesions exhibited significantly worse OS, with intermediate to high International Extranodal Lymphoma Study Group (IELSG) scores, compared with patients with RPVI-positive lesions. Among cases of APVT-positive lymphoma, the semiquantitative score of immunostaining of X-box-binding protein (XBP1) and CD44 demonstrated prognostic significance. Multivariate analysis confirmed independent associations between APVT and XBP1 and between CD44 staining and survival.
CONCLUSIONS: The presence of APVT and staining of XBP1 and CD44 are independently associated with survival among patients with PCNS-DLBCL. These features could be routinely assessed in histopathological and immunohistochemical specimens.

Entities:  

Keywords:  central nervous system; diffuse large B-cell lymphoma; histopathology; prognosis

Mesh:

Substances:

Year:  2013        PMID: 23482670      PMCID: PMC3661096          DOI: 10.1093/neuonc/not012

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  31 in total

1.  Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas.

Authors:  Nicky D'Haene; Xavier Catteau; Calliope Maris; Benoit Martin; Isabelle Salmon; Christine Decaestecker
Journal:  Br J Haematol       Date:  2007-12-13       Impact factor: 6.998

Review 2.  Primary lymphoma of the central nervous system: just DLBCL or not?

Authors:  Manuel Montesinos-Rongen; Reiner Siebert; Martina Deckert
Journal:  Blood       Date:  2008-09-18       Impact factor: 22.113

Review 3.  Primary central nervous system lymphoma report of 32 cases and review of the literature.

Authors:  Annie Dubuisson; Bruno Kaschten; Jacques Lénelle; Didier Martin; Pierre Robe; Marie-France Fassotte; Isabelle Rutten; Manuel Deprez; Achille Stevenaert
Journal:  Clin Neurol Neurosurg       Date:  2004-12       Impact factor: 1.876

4.  Intracerebral Human Lymphoma - An Experimental Model.

Authors:  János Schnur; Andrea Ladányi; László Kopper
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

5.  The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer.

Authors:  F P O'Malley; Z Saad; N Kerkvliet; G Doig; L Stitt; P Ainsworth; H Hundal; A F Chambers; D I Turnbull; V Bramwell
Journal:  Hum Pathol       Date:  1996-09       Impact factor: 3.466

6.  Primary central nervous system lymphoma: prognostication as per international extranodal lymphoma study group score and reactive CD3 collar.

Authors:  N Kumari; N Krishnani; A Rawat; V Agarwal; P Lal
Journal:  J Postgrad Med       Date:  2009 Oct-Dec       Impact factor: 1.476

7.  XBP1 is essential for survival under hypoxic conditions and is required for tumor growth.

Authors:  Lorenzo Romero-Ramirez; Hongbin Cao; Daniel Nelson; Ester Hammond; Ann-Hwee Lee; Hiderou Yoshida; Kazutoshi Mori; Laurie H Glimcher; Nicholas C Denko; Amato J Giaccia; Quynh-Thu Le; Albert C Koong
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

8.  TIMP1 induces CD44 expression and the activation and nuclear translocation of SHP1 during the late centrocyte/post-germinal center B cell differentiation.

Authors:  Young-Sik Kim; Dong-Wan Seo; Su-Kang Kong; Ju-Han Lee; Eung-Seok Lee; Maryalice Stetler-Stevenson; William G Stetler-Stevenson
Journal:  Cancer Lett       Date:  2008-05-23       Impact factor: 8.679

9.  Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience.

Authors:  Andrés J M Ferreri; Jean-Yves Blay; Michele Reni; Felice Pasini; Michele Spina; Achille Ambrosetti; Antonello Calderoni; Andrea Rossi; Vittorio Vavassori; Annarita Conconi; Liliana Devizzi; Françoise Berger; Maurilio Ponzoni; Bettina Borisch; Marianne Tinguely; Michele Cerati; Mario Milani; Enrico Orvieto; Juvenal Sanchez; Christine Chevreau; Stefania Dell'Oro; Emanuele Zucca; Franco Cavalli
Journal:  J Clin Oncol       Date:  2003-01-15       Impact factor: 44.544

10.  Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.

Authors:  Sonja Eberth; Björn Schneider; Andreas Rosenwald; Elena M Hartmann; Julia Romani; Margarete Zaborski; Reiner Siebert; Hans G Drexler; Hilmar Quentmeier
Journal:  BMC Cancer       Date:  2010-09-29       Impact factor: 4.430

View more
  16 in total

1.  The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.

Authors:  Jelena Jelicic; Milena Todorovic Balint; Maja Perunicic Jovanovic; Novica Boricic; Marjan Micev; Jelena Stojsic; Darko Antic; Bosko Andjelic; Jelena Bila; Bela Balint; Sonja Pavlovic; Biljana Mihaljevic
Journal:  Pathol Oncol Res       Date:  2016-01-11       Impact factor: 3.201

2.  Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression.

Authors:  Seung-Myoung Son; Sang-Yun Ha; Hae-Yong Yoo; Dongryul Oh; Seok-Jin Kim; Won-Seog Kim; Young-Hyeh Ko
Journal:  Mod Pathol       Date:  2016-09-30       Impact factor: 7.842

Review 3.  Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents.

Authors:  Andrés José María Ferreri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  How I treat CNS lymphomas.

Authors:  James L Rubenstein; Neel K Gupta; Gabriel N Mannis; Amanda K Lamarre; Patrick Treseler
Journal:  Blood       Date:  2013-08-20       Impact factor: 22.113

Review 5.  Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma.

Authors:  M Ponzoni; S Issa; T T Batchelor; J L Rubenstein
Journal:  Ann Oncol       Date:  2013-11-20       Impact factor: 32.976

6.  Cryptotanshinone Reverses Reproductive and Metabolic Disturbances in PCOS Model Rats via Regulating the Expression of CYP17 and AR.

Authors:  Jin Yu; Dongxia Zhai; Li Hao; Danying Zhang; Lingling Bai; Zailong Cai; Chaoqin Yu
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-03       Impact factor: 2.629

7.  MYC protein expression in primary diffuse large B-cell lymphoma of the central nervous system.

Authors:  Kamraan Z Gill; Fabio Iwamoto; Ashleigh Allen; Daniela Hoehn; Vundavalli V Murty; Bachir Alobeid; Govind Bhagat
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

8.  Brain stereotactic biopsy flow cytometry for central nervous system lymphoma characterization: advantages and pitfalls.

Authors:  Iole Cordone; Serena Masi; Mariantonia Carosi; Antonello Vidiri; Francesco Marchesi; Mirella Marino; Stefano Telera; Alessia Pasquale; Andrea Mengarelli; Laura Conti; Edoardo Pescarmona; Andrea Pace; Carmine M Carapella
Journal:  J Exp Clin Cancer Res       Date:  2016-08-27

Review 9.  Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?

Authors:  Valérie Dutoit; Denis Migliorini; Pierre-Yves Dietrich; Paul R Walker
Journal:  Front Oncol       Date:  2016-12-07       Impact factor: 6.244

Review 10.  Advances in Pathobiology of Primary Central Nervous System Lymphoma.

Authors:  Xue-Liang Yang; Yuan-Bo Liu
Journal:  Chin Med J (Engl)       Date:  2017-08-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.